Phase 3 N=118 Treatment

Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands

Scabies · Head Lice

Bottom Line

View on ClinicalTrials.gov: NCT03236168 ↗

Enrolled (actual)

118

Serious AEs

0.0%

Results posted

Jun 2019

Primary outcome: Primary: Number of Participants With Headlice — 3 Participants

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Ivermectin (Drug); Permethrin 5% (Drug); Malathion Shampoo 0.5% (Drug)
Age: Pediatric, Adult, Older Adult
Sex: All
Sponsor: London School of Hygiene and Tropical Medicine
Primary completion: Dec 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants With Headlice	—	—
SECONDARY Number of Participants With Headlice	—	—
SECONDARY Number of Participants With Headlice	—	—

Summary

This is a pilot study evaluating if treatment for scabies also treats headlice in the same community

Eligibility Criteria

Inclusion Criteria

All participants living in the community will be offered treatment

Exclusion Criteria

Patients with a contradindication to study medication
Patients unable to provide consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03236168). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.